All Relations between Bipolar Disorder and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Ben Wijnen, Maud Jansen, Annelieke van Velthoven, Imke Hanssen, Marloes Huijbers, Silvia Evers, Anne Specken. Trial-based economic evaluation of mindfulness-based cognitive therapy compared to treatment as usual for bipolar disorder. International journal of methods in psychiatric research. 2023-09-13. PMID:37700559. aim of this study was to assess the cost-effectiveness and cost-utility of mindfulness-based cognitive therapy (mbct) and treatment as usual (tau) compared to tau alone in adults with bipolar disorder (bd). 2023-09-13 2023-10-07 Not clear
M Ishrat Husain, Madeha Umer, Muqaddas Asif, Ameer B Khoso, Tayyeba Kiran, Moin Ansari, Huma Aslam, Moti Ram Bhatia, Farasat A Dogar, M Omair Husain, Hazrat A Khan, Ali A Mufti, Benoit H Mulsant, Farooq Naeem, Haider A Naqvi, Claire de Oliviera, M Sajjad Siddiqui, Asad Tamizuddin, Wei Wang, Juveria Zaheer, Nusrat Husain, Nasim Chaudhry, Imran B Chaudhr. Culturally adapted psychoeducation for bipolar disorder in a low-resource setting: protocol for a multicentre randomised controlled trial. BJPsych open. vol 8. issue 6. 2022-11-25. PMID:36426568. a pilot randomised controlled trial (rct) of a culturally adapted psychoeducation intervention for bipolar disorder (cape) in pakistan reported higher patient satisfaction, enhanced medication adherence, knowledge and attitudes regarding bipolar disorder, and improvement in mood symptom scores and health-related quality of life measures compared with treatment as usual (tau). 2022-11-25 2023-08-14 Not clear
Wen Shao, Yi Zheng, Qingxia Li, Kangning Shao, Fujun Zhao, Lin Guan, Zhixia Zhang, Fenghua L. Evaluation of Electroconvulsive Therapy in Adolescents With Major Depressive and Bipolar Disorders: A Retrospective Analysis. The journal of ECT. 2022-11-22. PMID:36413657. this study aims to provide an evaluation of electroconvulsive therapy (ect) in hospitalized adolescents with major depressive and bipolar disorders by examining its treatment outcomes as well as comparing it with outcomes of hospitalized patients, treated as usual (tau). 2022-11-22 2023-08-14 Not clear
Rebecca A DeGiosio, Melanie J Grubisha, Matthew L MacDonald, Brandon C McKinney, Carlos J Camacho, Robert A Swee. More than a marker: potential pathogenic functions of MAP2. Frontiers in molecular neuroscience. vol 15. 2022-10-03. PMID:36187353. though pathology of tau has been well appreciated in the context of neurodegenerative disorders, the consequences of pathologically dysregulated map2 have been little explored, despite alterations in its immunoreactivity, expression, splicing and/or stability being observed in a variety of neurodegenerative and neuropsychiatric disorders including huntington's disease, prion disease, schizophrenia, autism, major depression and bipolar disorder. 2022-10-03 2023-08-14 Not clear
Antonio Del Casale, Leda Marina Pomes, Luca Bonanni, Federica Fiaschè, Clarissa Zocchi, Alessio Padovano, Ottavia De Luca, Gloria Angeletti, Roberto Brugnoli, Paolo Girardi, Robert Preissner, Marina Borro, Giovanna Gentile, Maurizio Pompili, Maurizio Simmac. Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study. Journal of personalized medicine. vol 12. issue 2. 2022-02-25. PMID:35207804. the main aim of this study was to evaluate the clinical changes after pgt in patients with trd (two or more recent failed psychopharmacological trials) affected by bipolar disorder (bd) or major depressive disorder (mdd) compared to a control group with treatment as usual (tau). 2022-02-25 2023-08-13 Not clear
Wendy Theresa Jones, Sarah Peters, Rory Edward Byrne, David Shiers, Heather Law, Sophie Parke. "It felt very special, it felt customised to me"-A qualitative investigation of the experiences of participating in a clinical trial of CBT for young people at risk of bipolar disorder. Psychology and psychotherapy. vol 94. issue 3. 2021-10-28. PMID:33063921. the bipolar at risk trial (bart) was a feasibility randomized controlled trial investigating cognitive behavioral therapy (cbt) compared with treatment as usual (tau) in young people at high risk of developing bipolar disorder (bd). 2021-10-28 2023-08-13 human
Rebecca A Janis, Gary M Burlingame, Hal Svien, Jennifer Jensen, Rachel Lundgree. Group therapy for mood disorders: A meta-analysis. Psychotherapy research : journal of the Society for Psychotherapy Research. vol 31. issue 3. 2021-05-21. PMID:32930060. similarly, group therapy for bipolar disorder produced superior outcomes to tau. 2021-05-21 2023-08-13 Not clear
Jayesh Kamath, Sara Wakai, Wanli Zhang, Karen Kesten, Deborah Shelton, Robert Trestma. Adaptation of the Texas Implementation Medication Algorithm for Bipolar Disorder in Adult Female Offenders. International journal of offender therapy and comparative criminology. vol 60. issue 11. 2018-01-25. PMID:25829456. the objective of the present study was to evaluate effectiveness of algorithm (texas implementation of medication algorithm [tima])-driven treatment of bipolar disorder (bd) compared with treatment as usual (tau) in the correctional environment. 2018-01-25 2023-08-13 Not clear
Heather A MacPherson, Sally M Weinstein, David B Henry, Amy E Wes. Mediators in the randomized trial of Child- and Family-Focused Cognitive-Behavioral Therapy for pediatric bipolar disorder. Behaviour research and therapy. vol 85. 2017-09-08. PMID:27567973. this study evaluated mediators in the randomized trial of child- and family-focused cbt (cff-cbt) versus treatment as usual (tau) for pediatric bipolar disorder (pbd), adjunctive to pharmacotherapy. 2017-09-08 2023-08-13 Not clear
Sally M Weinstein, David B Henry, Andrea C Katz, Amy T Peters, Amy E Wes. Treatment moderators of child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry. vol 54. issue 2. 2016-10-28. PMID:25617252. prior work has demonstrated the efficacy of child- and family-focused cognitive-behavioral therapy (cff-cbt) versus enhanced treatment as usual (tau; unstructured psychotherapy) for pediatric bipolar disorder (pbd). 2016-10-28 2023-08-13 Not clear
Joel Jakobsson, Erik Pålsson, Carl Sellgren, Frida Rydberg, Agneta Ekman, Henrik Zetterberg, Kaj Blennow, Mikael Landé. CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder. The British journal of psychiatry : the journal of mental science. vol 208. issue 2. 2016-10-27. PMID:26541689. cacna1c polymorphism and altered phosphorylation of tau in bipolar disorder. 2016-10-27 2023-08-13 Not clear
Joel Jakobsson, Erik Pålsson, Carl Sellgren, Frida Rydberg, Agneta Ekman, Henrik Zetterberg, Kaj Blennow, Mikael Landé. CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder. The British journal of psychiatry : the journal of mental science. vol 208. issue 2. 2016-10-27. PMID:26541689. we found a significant association between the risk allele in rs1006737 and a decreased csf hyperphosphorylated tau/total tau ratio in patients with bipolar disorder, thus linking variation in the cacna1c gene to a neurochemical marker of neuroaxonal plasticity in those with this disorder. 2016-10-27 2023-08-13 Not clear
Thekiso B Thekiso, Philip Murphy, Jennie Milnes, Kathryn Lambe, Aisling Curtin, Conor K Farre. Acceptance and Commitment Therapy in the Treatment of Alcohol Use Disorder and Comorbid Affective Disorder: A Pilot Matched Control Trial. Behavior therapy. vol 46. issue 6. 2016-06-07. PMID:26520216. fifty-two participants were included in the study, of whom 26 were patients with aud and either depression or bipolar disorder treated with act group therapy in parallel with tau (inpatient integrated treatment) and 26 were matched controls who had received tau alone. 2016-06-07 2023-08-13 human
Sindre Rolstad, Joel Jakobsson, Carl Sellgren, Carl-Johan Ekman, Kaj Blennow, Henrik Zetterberg, Erik Pålsson, Mikael Landé. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls. PloS one. vol 10. issue 5. 2016-04-27. PMID:25954806. csf concentrations of total and phosphorylated tau, amyloid beta (aβ)1-42, ratios of aβ42/40 and aβ42/38, soluble amyloid precursor protein α and β, and neurofilament light chain protein were analyzed in relation to neuropsychological performance in 82 euthymic bipolar disorder patients and 71 healthy controls. 2016-04-27 2023-08-13 Not clear
Tina R Goldstein, Rachael K Fersch-Podrat, Maribel Rivera, David A Axelson, John Merranko, Haifeng Yu, David A Brent, Boris Birmahe. Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial. Journal of child and adolescent psychopharmacology. vol 25. issue 2. 2016-01-04. PMID:25010702. the purpose of this study was to conduct a pilot randomized trial of dialectical behavior therapy (dbt) versus psychosocial treatment as usual (tau) for adolescents diagnosed with bipolar disorder (bp). 2016-01-04 2023-08-13 Not clear
T Perich, V Manicavasagar, P B Mitchell, J R Ball, D Hadzi-Pavlovi. A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder. Acta psychiatrica Scandinavica. vol 127. issue 5. 2013-08-30. PMID:23216045. to compare the efficacy of mindfulness-based cognitive therapy (mbct) plus treatment as usual (tau) to tau alone for patients with bipolar disorder over a 12-month follow-up period. 2013-08-30 2023-08-12 Not clear
Megan J Ehret, Deborah Shelton, William Barta, Robert Trestman, Annette Maruca, Jayesh Kamath, Leslie Gola. Medication adherence among female inmates with bipolar disorder: results from a randomized controlled trial. Psychological services. vol 10. issue 1. 2013-08-05. PMID:23421363. using a prospective longitudinal analysis of secondary data and chart data, a comparison was made between participants who were assigned either to tima or tau and treated for 12 weeks for either bipolar disorder type i or ii. 2013-08-05 2023-08-12 human
Megan J Ehret, Deborah Shelton, William Barta, Robert Trestman, Annette Maruca, Jayesh Kamath, Leslie Gola. Medication adherence among female inmates with bipolar disorder: results from a randomized controlled trial. Psychological services. vol 10. issue 1. 2013-08-05. PMID:23421363. to describe the differences in medication adherence between 2 groups of inmates in the connecticut department of correction diagnosed with bipolar disorder treated with either the texas implementation of medication algorithm (tima) for bipolar disorder or treatment as usual (tau). 2013-08-05 2023-08-12 human
Kohei Shimada, Yumiko Motoi, Koichi Ishiguro, Taiki Kambe, Shin-Ei Matsumoto, Masako Itaya, Miyuki Kunichika, Hideo Mori, Atsuko Shinohara, Momoko Chiba, Yoshikuni Mizuno, Takashi Ueno, Nobutaka Hattor. Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: implications of autophagy promotion. Neurobiology of disease. vol 46. issue 1. 2012-11-20. PMID:22249108. lithium, a drug used to treat bipolar disorders, has a variety of neuroprotective mechanisms including inhibition of glycogen synthase kinase-3 (gsk-3), a major tau kinase. 2012-11-20 2023-08-12 mouse
William V Bobo, Richard A Epstein, Alan Lynch, Tynya D Patton, Nicholas A Bossaller, Richard C Shelto. A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder. Clinical neuropharmacology. vol 34. issue 6. 2012-08-20. PMID:22104634. to compare adjunctive long-acting injectable risperidone plus treatment as usual (rlai+tau) versus tau alone for relapse, rehospitalization, and urgent care events in patients with bipolar disorder in routine care settings. 2012-08-20 2023-08-12 Not clear